Predictors of Days Unable to Work Among Genotype 1 Treatment-NaiVE Chronic Hepatitis C Patients: Post-Hoc Analyses of Data From Phase 3 Advance and Illuminate Studies

被引:0
|
作者
Hernandez, Ning C.
Vera-Llonch, Montserrat
Aggarwal, Jyoti
Donepudi, Mrudula
Younossi, Zobair M.
Goss, Thomas F.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S955 / S955
页数:1
相关论文
共 50 条
  • [1] PREDICTORS OF DAYS UNABLE TO WORK AMONG GENOTYPE 1 TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS: POST-HOC ANALYSES OF DATA FROM PHASE 3 ADVANCE AND ILLUMINATE STUDIES
    Hernandez, N.
    Vera-Llonch, M.
    Aggarwal, J.
    Donepudi, M.
    Younossi, Z.
    Goss, T. F.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S463 - S463
  • [2] Predictors of Fatigue Severity among Treatment-Naive Genotype 1 Chronic Hepatitis C Patients: Post-Hoc Analyses of Data from ADVANCE and ILLUMINATE
    Muir, Andrew
    Sherman, Kenneth
    Aggarwal, Jyoti
    Goss, Thomas
    Donepudi, Mrudula
    Martin, Marie
    Vera-Llonch, Montserrat
    Younossi, Zobair
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S573 - S574
  • [3] HEALTH-RELATED QUALITY-OF-LIFE AMONG GENOTYPE 1 TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS RECEIVING TELAPREVIR COMBINATION TREATMENT: POST-HOC ANALYSES OF DATA FROM THE ADVANCE TRIAL
    Younossi, Z.
    Aggarwal, J.
    Martin, M.
    Hernandez, N.
    Donepudi, M.
    Bayliss, M.
    Goss, T.
    Vera-Llonch, M.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S462 - S463
  • [4] Health-Related Quality-of-Life Among Genotype 1 Treatment-NaiVE Chronic Hepatitis C Patients Receiving Telaprevir Combination Treatment: Post-Hoc Analyses of Data From the Advance Trial
    Younossi, Zobair M.
    Aggarwal, Jyoti
    Martin, Marie
    Hernandez, Ning C.
    Donepudi, Mrudula
    Bayliss, Martha S.
    Goss, Thomas F.
    Vera-Llonch, Montserrat
    GASTROENTEROLOGY, 2012, 142 (05) : S955 - S955
  • [5] WORK PRODUCTIVITY AMONG GENOTYPE 1 HEPATITIS C VIRUS (HCV) TREATMENT-NAIVE PATIENTS RECEIVING TELAPREVIR-BASED TREATMENT REGIMENS: RESULTS FROM ADVANCE AND ILLUMINATE STUDIES
    Thal, G.
    Nuyts, G.
    Mcallister, S.
    Luo, D.
    Muir, A. J.
    Sherman, K. E.
    Adda, N.
    Wright, C.
    Beumont, M.
    Gavart, S.
    VALUE IN HEALTH, 2011, 14 (03) : A184 - A184
  • [6] Work productivity among treatment-naive patients with genotype 1 chronic hepatitis C infection receiving telaprevir combination treatment
    Aggarwal, J.
    Vera-Llonch, M.
    Donepudi, M.
    Suthoff, E.
    Younossi, Z.
    Goss, T. F.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (01) : 8 - 17
  • [7] Impact of Telaprevir-Based Treatment Regimens on Fatigue in Genotype 1 HCV Treatment-NaiVE Patients: Results From Advance and Illuminate Studies
    Muir, Andrew J.
    Gavan, Sandra
    Thal, Gary
    Nuyts, Guy
    McCallister, Scott
    Beumont-Mauviel, Maria
    Luo, Don
    Adda, Nathalie
    Wright, Christopher I.
    Sherman, Kenneth E.
    GASTROENTEROLOGY, 2011, 140 (05) : S944 - S945
  • [8] IMPACT OF TELAPREVIR-BASED TREATMENT REGIMENS ON FATIGUE IN GENOTYPE 1 HCV TREATMENT-NAIVE PATIENTS: RESULTS FROM ADVANCE AND ILLUMINATE STUDIES
    Gavart, S.
    Sherman, K. E.
    Thal, G.
    Nuyts, G.
    McAllister, S.
    Beumont, M.
    Luo, D.
    Adda, N.
    Wright, C.
    Muir, A. J.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S477 - S477
  • [9] HEALTH-RELATED QUALITY-OF-LIFE AMONG GENOTYPE 1 TREATMENT-EXPERIENCED CHRONIC HEPATITIS C PATIENTS: POST-HOC ANALYSES FROM THE REALIZE STUDY
    Sherman, K.
    Muir, A.
    Aggarwal, J.
    Donepudi, M.
    Goss, T.
    Martin, M.
    Vera-Llonch, M.
    Younossi, Z.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S372 - S372
  • [10] Sofosbuvir plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 or 3 infection in India
    Shah, S. R.
    Chowdhury, A.
    Mehta, R.
    Kapoor, D.
    Duseja, A.
    Koshy, A.
    Shukla, A.
    Sood, A.
    Madan, K.
    Sud, R.
    Nijhawan, S.
    Pawan, R.
    Prasad, M.
    Kersey, K.
    Jiang, D.
    Svarovskaia, E.
    Doehle, B.
    Kanwar, B.
    Subramanian, M.
    Acharya, S. K.
    Sarin, S.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (05) : 371 - 379